What are the clinical features of Guillain‑Barré syndrome?

Clinical Features of Guillain-Barré Syndrome

GBS should be suspected in any patient presenting with rapidly progressive bilateral weakness of the legs and/or arms that reaches maximum disability within 2 weeks, accompanied by decreased or absent reflexes, in the absence of CNS involvement. 1

Typical Presentation

The classic sensorimotor form of GBS follows a characteristic pattern:

Motor Features

• Weakness pattern: Begins distally in the legs, then ascends to involve the arms and cranial muscles 1
• Bilateral involvement: Always bilateral, though can be asymmetrical 1
• Reflexes: Decreased or absent in most patients at presentation, and in almost all patients at nadir 1
• Progression timeline: Maximum disability typically reached within 2 weeks of onset 1

Critical timing caveat: If maximum disability occurs within 24 hours or after 4 weeks from onset, strongly consider alternative diagnoses 1

Sensory Features

• Distal paresthesias or sensory loss 1
• Usually accompanies or precedes weakness 1
• Pain is frequently reported (muscular, radicular, or neuropathic) 1

Autonomic Dysfunction

Dysautonomia is common and includes: 1

• Blood pressure instability
• Heart rate abnormalities
• Pupillary dysfunction
• Bowel or bladder dysfunction

Cranial Nerve Involvement

• Progresses to affect cranial muscles in the classic ascending pattern 1
• Bulbar palsy occurs in approximately 47.5% of pediatric cases 2

Atypical Presentations

Failure to recognize atypical presentations causes diagnostic delays, particularly in young children (<6 years old). 1

Atypical Motor Patterns

• Weakness can be asymmetrical or predominantly proximal/distal 1
• May start in legs, arms, or simultaneously in all limbs 1
• Pure motor variant may show normal or even exaggerated reflexes (particularly in AMAN subtype) 1

Pediatric-Specific Features

Children under 6 years may present with: 1

• Poorly localized pain
• Refusal to bear weight
• Irritability
• Meningism
• Unsteady gait
• Leg pain as the most common initial symptom 2

Preceding Symptoms

• Severe diffuse pain or isolated cranial nerve dysfunction can precede weakness 1
• About two-thirds report infection symptoms in the 6 weeks before onset 1
• Respiratory tract infections are most common, followed by diarrheal illness 2

Clinical Variants

Several distinct variants exist that do not progress to the classic pattern: 1

Pure Motor Variant

• Weakness without sensory signs
• May maintain normal reflexes throughout disease course

Regional Variants

• Bilateral facial palsy with paresthesias (cranial nerve limited)
• Pharyngeal-cervical-brachial weakness (upper limb limited)
• Paraparetic variant (lower limb limited)

Miller Fisher Syndrome (MFS)

Classic triad: 1

• Ophthalmoplegia
• Areflexia
• Ataxia

Debated Variants

The following share features with GBS but may not fulfill diagnostic criteria: 1

• Pure sensory variant
• Pure sensory ataxia
• Bickerstaff brainstem encephalitis (BBE) - presents with MFS features plus impaired consciousness and pyramidal tract signs

Disease Course

Temporal Pattern

• Acute or subacute onset 1
• Progressive phase: Typically reaches maximum disability within 2 weeks 1
• Plateau phase: Lasts days to weeks or months 1
• Recovery phase: 60-80% walk independently at 6 months 1
• Monophasic course: GBS does not relapse, though treatment-related fluctuations occur in a minority 1
• Recurrence is rare: Only 2-5% of patients 1

Severe Complications

• Respiratory failure: Occurs in approximately 20% of patients, requiring mechanical ventilation 1
• Cardiac arrhythmias: Due to autonomic involvement 1
• Mortality: 3-10% even with optimal care 1

Key Diagnostic Red Flags

Consider alternative diagnoses if: 1

• Maximum disability reached within 24 hours of onset
• Progression continues beyond 4 weeks (consider acute-onset CIDP, which occurs in ~5% initially diagnosed as GBS) 3
• CNS involvement is present
• Reflexes remain brisk throughout (except in pure motor AMAN variant)

The heterogeneity of GBS presentations demands high clinical suspicion, particularly when evaluating young children or patients with atypical weakness patterns. Early recognition is critical given the potential for rapid respiratory compromise and the time-sensitive nature of immunomodulatory treatments.